BridgeMD
New treatment option for Intellectual Disability
Official title Harnessing Communication Preferences
ClinicalTrials.gov ID: NCT07278544
What this study is testing
- What it's testing
- The goal of this clinical trial is to evaluate how preference for communication approach (e.g., using a touch talker versus picture cards) impacts treatment maintenance in the context of treatment to reduce challenging behavior exhibited by individuals with intellectual and/or developmental disabilities. As well, the clinical trial will evaluate how this preference impacts treatment relapse when care providers implement intervention and will identify potential demographic variables (e.g., age and symptom severity) that affect outcomes.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 2 to 90
You may be able to join if
- 2 years old and older.
- Diagnosis of intellectual or developmental disability.
- Referred for assessment and treatment of challenging behavior.
You likely can't join if
- Challenging behavior does not occur within the context of structured assessment, eliminating the ability to identify its operant function, or the...
- Communicate functionally using vocal/verbal communication.
- Can only identify one proficient AAC strategy.
The study team makes the final eligibility decision.
Where it's taking place
- Athens, Georgia, United States
- Iowa City, Iowa, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 2 years to 90 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Athens, Georgia, United States; Iowa City, Iowa, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.